SynBioBeta Digest Archive

News Digest #330 – Tomorrow @ 8am on SynBioBeta Live: Pam Silver, Esther Dyson, Drew Endy, Steve Kwast, Karen Watson & Nishan Degnarain – We’re not going back to normal.

News Digest #329 – Today 8am SynBioBeta’s Antibody-Palooza featuring Joe DeRisi

News Digest #328 – 🦠Synthetic biology investor panel, coronavirus antibodies roundtable, and more

News Digest #327 – Happy brain chemicals, SGI-DNA is now Codex, and biology in your phone

News Digest #326 – This week: Drew Endy, 8 am Monday. Illumina’s Chief Medical Officer, 8:30 am Wednesday.

News Digest #325 – New targets for SARS-CoV-2 vaccines, the state of the industry, and what swabbing the NYC subway is telling us

News Digest #324 – SynBioBeta State of the Industry with Craig Venter, George Church, Jim Collins and Drew Endy

News Digest #323 – Three COVID-19 events this week, and three reasons for hope right now

News Digest #322 – Zymergen buys enEvolv, gene editing webinar, and kids town hall today!

News Digest #321 – New events: Kids Town Halls + Moderna + Inscripta and Impossible’s $500M raise!

News Digest #320 – COVID-19 Town Hall today at 7:30 am, Mammoth’s 30 minute CRISPR test, Atomwise’s $1B deal, and Twist’s SARS-CoV-2 reference standard

News Digest #319 – COVID-19 town hall #2, digitizing biology + Thermo Fisher buys Qiagen for $10B

News Digest #318 – SynBioBeta COVID-19 town hall tomorrow, Saturday @ 9-10a Pacific.

News Digest #317 – PvP Biologics is acquired for $330M, Evonetix raises $30M, C16 raises $20M, detecting Coronavirus with CRISPR

News Digest #316 – Three signs the bioeconomy is in action, Twist raises $130M, and the future of agriculture webinar tomorrow at 9AM Pacific

News Digest #315 – AquaBounty raises $15.5 million, Bill Gates calls for more gene editing for healthcare, and Ginkgo’s Creative Residency

News Digest #314 – Beam’s $207M IPO! Genomatica’s new bionylon, a new Good Genes issue, and Twist settles with Agilent.

News Digest #313 – Mammoth raises $45 million, a16z’s new $750M bio fund, the fight against coronavirus, and China out-invests the U.S. in the global bioeconomy

News Digest #312 – Memphis Meats raises $161M, a new mycelium biofabrication platform, and better food with gene editing

News Digest #311 – My interview with Ginkgo’s Reshma Shetty, some news on the U.S. bioeconomy, $48 million for DNA data storage

News Digest #310 – The end of the flu, transforming oceans and agriculture with synthetic biology

News Digest #309 – What’s up with CRISPR Prime, cell-free grows up, and Intrexon is now Precigen

News Digest #308 – SynBioBeta’s most popular articles of 2019, synthetic biology and climate change, and using the cloud to solve life science’s big data problem

News Digest #307 (December 11, 2019) – Inscripta raises $125M, Sanofi buys Synthorx for $2.5B, Meatable raises €9M

News Digest #306 (December 4, 2019) – Digitizing biology and scaling precision medicine companies + Fermenting the future of healthy aging

News Digest #305 (November 27, 2019) – Can synthetic biology inspire the next wave of AI? A personal look at Rosalind Franklin. Carverr gets $1.9M for traceability tech.

News Digest #304 (November 20, 2019) – Gore-Tex is getting synthetic biology. Pesticides and the modern age. What happened at iGEM 2019.

News Digest #303 (November 13, 2019) – eGenesis raises $100m, Eric Schmidt at SynBioBeta

News Digest #302 (November 6, 2019) – Geltor’s new partnership + Petrochemistry in your cupcake? + are you budgeting for SynBioBeta 2020?

News Digest #301 (October 30, 2019) – Exploring the dark corners of the genome, neural networks will personalize medicine, GMO mosquitoes

News Digest #300 (October 23, 2019) – Issue #300! CRISPR prime, 2019’s biggest research papers, ArsenalBio debuts with $85m, and Refactor Capital’s new fund

News Digest #299 (October 16, 2019) – Conference recaps, Good Food Institute awards + Azitra, Provivi and Future Meat funding rounds

News Digest #298 (October 10, 2019) – The Bioeconomy Alliance goes to DC, Ginkgo’s $350M fund announcement, and coming down from SynBioBeta 2019

News Digest #297 (October 4, 2019) – SynBioBeta Day 3 Recap: How to tell the story of 21st-century biology, BetaSpace 2020, and the Startup Draft

News Digest #296 (October 3, 2019) – SynBioBeta 2019 Day 2 Recap (sponsored by Fifty Years)

News Digest #295 (October 2, 2019) – SynBioBeta Day 1 recap: Inscripta’s new digital desktop genome editing platform, and Ginkgo and Berkeley Light’s $150M collaboration (sponsored by Codexis)

News Digest #294 (September 25, 2019) – Six days to SynBioBeta 2019! Plus: DCVC raises $725M, Ginkgo Bioworks raises $290M (sponsored by Twist Bioscience)

News Digest #293 (September 18, 2019) – 8 Tech Titans Investing in Synthetic Biology, The Netflix of Antibodies, Say Hello to Berkeley Lights (sponsored by Ginkgo Bioworks)

News Digest #292 (September 11, 2019) – Scaling microbiome companies, Eric Schmidt @ SynBioBeta 2019 and $25m for SGI-DNA (sponsored by Azitra)

News Digest #291 (September 4, 2019) – Live today @ 10am PT – SynBioBeta preview! Plus: designer proteins, designer biomaterials, and a video on the synthetic biology future. (sponsored by Geltor)

News Digest #290 (August 28, 2019) – Engineering your immune system. Food and apparel industry reports. Plan for success at SynBioBeta 2019! (sponsored by Distributed Bio)

News Digest #289 (August 21, 2019) – Gene editing reborn. Meet the DNA assembly line. Motif FoodWorks’ $27.5M.

News Digest #288 (August 14, 2019) – 5 Reasons Jeff Bezos Should Bet Big On Synthetic Biology

News Digest #287 (August 7, 2019) – $89M for Inari, $72M for LanzaTech, DNA data storage, DNA assembly line, 5 automation myths (sponsored by Labcyte)

News Digest #286 (July 31, 2019) – Meet Inscripta live at 10am today, Benchling’s $34.5M, Startup Draft deadline today, and Bio-Belt Ambassadors

News Digest #285 (July 24, 2019) – UK Synthetic biology, where there’s a will there’s a whey, $75M for Joyn + €17M for 3F BIO (sponsored by Analytik Jena)

News Digest #284 (July 17, 2019) – Meet the 37 synthetic biology companies that raised $1.2b in a record Q2.

News Digest #283 (July 10, 2019) – What’s trending in DNA synthesis and storage, Checkerspot’s big announcement, and this week’s podcast (sponsored by Evonetix)

News Digest #282 (July 3, 2019) – Synthetic biology and consumer products, see the October schedule, supercharging design exchange & our research roundup (sponsored by P&G)

News Digest #281 (June 26, 2019) – Carbon recycling startups, Codexis raises $50M, a roadmap for the bioeconomy, early bird ends Friday

News Digest #280 (June 19, 2019) – Nobel Laureate Frances Arnold to keynote SynBioBeta + download our cannabinoid fermentation industry report

News Digest #279 (June 12, 2019) – Spiber in Japan, Codexis/Tate & Lyle, Ginkgo/Synlogic, early bird ends Friday (sponsored by Spiber)

News Digest #278 (June 5, 2019) AI and synthetic biology, Riffyn, Kytopen and Lygos raise $20M

News Digest #277 (May 29, 2019) – Synthetic biology disrupting food and ag? + Wild Earth’s $11M, Solugen’s $32M + Synlogic and Roche partner up. (sponsored by Conagen)

News Digest #276 (May 22, 2019) – Read our special on chemicals and materials + 38.5m for DNA Script, Warp Drive Bio acquired, recoded genomes and more.

News Digest #275 (May 15, 2019) – Benchmarking in synbio, new industry investors, inhibiting CRISPR (sponsored by Berkeley Lights)

News Digest #274 (May 8, 2019) – New report on DNA data storage, Beyond Meat soars 163% in the best IPO in 2019 (sponsored by West Oxford Advisors)

News Digest #273 (May 1, 2019) – Cell-free tech, Impossible Whoppers, Clara Foods, Sherlock Biosciences, Amyris and more

BetaSpace newsletter 2 (May 1, 2019) – BetaSpace news: NASA’s Chris McKay – a five-year plan to settle the solar system – webinar on May 7

News Digest #272 (April 24, 2019) – SynBioBeta early bird ends next week! BetaSpace + LA Times, Green New Deal, Autolus IPO, $45M for David Baker

News Digest #271 (April 17, 2019) – How synthetic biology will disrupt pharma: Jake Glanville, Aaron Sato, and JC Gutierrez

News Digest #270 (April 10, 2019) – Our $652m Q1 report, cell-free tech, and the BIG Economist cover story

News Digest #269 – (April 3, 2019) – I guess AI can’t take a joke – engineered cell therapies for cancer, diabetes + space + £6.5m for Oxford Genetics

SynBioBeta Digest Archive

Editor’s picks

How genetic modification of microbes that help make foods can contribute to a more stable (and delicious) food chain

With $300 Million In New Funding, Zymergen Aims To Sustainably Transform The $3 Trillion Chemical And Materials Industry

A Living Night Light Made From Microbes Could Be All The Rage This Christmas

Jennifer Doudna’s New Gene Editing Company Launches With A $20 Million Round To Develop Genetic Medicines

Could A Chief Biology Officer Make Your Company More Profitable?

You’ve Heard Of Computer-Aided Design. What About Computer-Aided Biology?

A New Approach To A Deadly Breast Cancer Offers Hope To The Black Women It Affects Most

How One Unassuming Little Protein Makes Coronavirus A Killer

Bioeconomy Powerhouse Berkeley Lights Nearly Triples Since IPO, Now Valued At $3.9 Billion

Synthetic Biology Versus Coronavirus: Three Women In A Cutting-Edge Field Using Biological Engineering To Save Lives

Synthetic Biology Startups Raised $3 Billion In The First Half Of 2020

Could Fermentation Power The Future Of Plant-Based Foods? Motif FoodWorks Thinks Yes.

Demetrix Is Scaling The Cannabinoid Industry

The Drug Supply Chain Is Broken. A New Breakthrough Paves The Way For On-Demand Plant-Based Medicines

How Do We Safely Reopen Schools And Work? Cheap, Fast Testing, Enabled By A $5 Million XPRIZE

How A Newly Public Synthetic Biology Company Pivoted To The Pandemic: Up Close And Personal With Twist Bioscience

A Virtual Drug Discovery Company—With No Lab Of Its Own—Partners With Roche To Fight Cancers In The Brain

The Rush For Hand Sanitizers Is A Boom For Hand Moisturizers. This Startup Has A Solution For Both.

Synthetic Biology Reports

Job opportunities

Videos

SynBioBeta Podcast! Hosted Live and exclusively for our Bioeconomy Hub Members.

SynBioBeta Town Hall on sequencing’s vital new role in fighting pandemics: A COVID-19 update from Illumina leadership

SynBioBeta State of the Industry Town Hall with Drew Endy

COVID-19 Town Hall with Nanome: Exploring the coronavirus spike protein in 3D virtual reality

SynBioBeta State of the Industry Town Hall with James Collins

SynBioBeta State of the Industry Town Hall with George Church

SynBioBeta COVID-19 Town Hall with JCVI’s Richard Scheuermann on coronavirus immune epitopes

COVID-19 Town Hall on Ginkgo’s $25M pledge and the community’s responses

COVID-19 Town Hall on environmental sampling for coronavirus